Generic Name and Formulations:
Granisetron (as HCl) 1mg/5mL; soln; orange-flavor.
Indications for GRANISOL:
Prevention of nausea and vomiting associated with chemotherapy (including high-dose cisplatin) or with radiation (including total body irradiation and fractionated abdominal radiation).
Chemotherapy: give only on the days chemo is given. 2mg once daily up to 1 hour before chemo; or, 1mg up to 1 hour before chemo, then 1mg 12 hours after 1st dose. Radiation: 2mg once daily within 1 hour of radiation.
Pre-existing arrhythmias or cardiac conduction disorders. Increased risk of QT prolongation: cardiac disease, on cardio-toxic chemotherapy, electrolyte abnormalities and/or concomitant drugs that prolong the QT interval. Abdominal surgery. May mask progressive ileus and/or gastric distention. Pregnancy (Cat.B). Nursing mothers.
Caution with drugs that affect CYP450 or drugs known to prolong the QT interval and/or are arrhythmogenic.
Selective 5-HT3 receptor antagonist.
Headache, asthenia, diarrhea, constipation, abdominal pain; QT prolongation.
Endocrinology Advisor Articles
- Higher BUN May Increase Risk for Incident Diabetes
- Efficacy of Novel GLP-1 Receptor Agonist Drug Device Examined
- Takeout Food May Increase Adverse Health Consequences in Children
- Nonhormonal Options Available for Menopause Symptom Relief
- Plasma Volume Changes Mediate Risk of CV Mortality With Empagliflozin
- New Consensus Recommendations on Use of Continuous Glucose Monitoring
- Does Genetic Susceptibility Lead to Late-Onset Type 1 Diabetes?
- Clinical Outcomes in T2D: Low-Carbohydrate vs Calorie-Restricted Diet
- New Continuous Glucose Monitoring System Now Available for Medicare Patients
- Text Message-Delivered Interventions Effective for Weight Management
- Effect of Intra-Articular Depot Betamethasone on Insulin Resistance in T2D
- Gastric Bypass vs Sleeve Gastrectomy Outcomes in Morbid Obesity
- Acute Kidney Injury Increases Risk for Postdischarge Hypoglycemia in Diabetes
- Novel Deep Learning System May Help Identify Diabetic Retinopathy
- Trends in CVD, Risk Factors, and Medications in Children With T1D